IGBA launches a whitepaper: A vision for the generic and biosimilar medicines industry
The International Generic and Biosimilar Medicines Association (IGBA) has announced the launch of a whitepaper: A vision for the generic and biosimilar medicines industry, which covers the strong contribution of this pharmaceutical sector to global health outcomes and economies, the opportunities, challenges and disruptions for the industry
IGBA Launches A Whitepaper: A Vision For The Gener | 08/07/2021 | By Darshana | 204
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy